Article Details
Retrieved on: 2021-04-12 09:42:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Exscientia was the first company to start human trials of a new drug designed using artificial intelligence (AI) last year, and now says it has started ...
Article found on: pharmaphorum.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here